BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21300373)

  • 1. Calcium absorption in very low birth weight infants with and without bronchopulmonary dysplasia.
    Hicks PD; Rogers SP; Hawthorne KM; Chen Z; Abrams SA
    J Pediatr; 2011 Jun; 158(6):885-890.e1. PubMed ID: 21300373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phosphorus and calcium metabolism of premature infants fed human milk and formulated milk].
    Schilling R; Haschke F; Kovarik J; Woloszczuk W
    Padiatr Padol; 1982; 17(4):667-74. PubMed ID: 7155613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of bronchopulmonary dysplasia and increased risk of feeding desaturation and growth delay in very low birth weight preterm infants.
    Wang LY; Luo HJ; Hsieh WS; Hsu CH; Hsu HC; Chen PS; Chiu NC; Lee WT; Jeng SF
    Pediatr Pulmonol; 2010 Feb; 45(2):165-73. PubMed ID: 20054861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic hypertension in very low-birth weight infants with bronchopulmonary dysplasia: incidence and risk factors.
    Alagappan A; Malloy MH
    Am J Perinatol; 1998 Jan; 15(1):3-8. PubMed ID: 9475679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchopulmonary dysplasia in very low birth weight infants is associated with prolonged hospital stay.
    Klinger G; Sirota L; Lusky A; Reichman B
    J Perinatol; 2006 Oct; 26(10):640-4. PubMed ID: 17006525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the dual stable isotope method to assess calcium absorption and retention in premature infants.
    Hillman LS
    J Pediatr; 2011 Jun; 158(6):876-7. PubMed ID: 21429507
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
    McEvoy C; Bowling S; Williamson K; McGaw P; Durand M
    Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
    Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
    Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight loss and bronchopulmonary dysplasia in very low birth weight infants.
    Maayan-Metzger A; Mazkereth R; Kuint J
    Fetal Pediatr Pathol; 2008; 27(4-5):215-22. PubMed ID: 18800264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchopulmonary dysplasia predicts adverse developmental and clinical outcomes in very-low-birthweight infants.
    Jeng SF; Hsu CH; Tsao PN; Chou HC; Lee WT; Kao HA; Hung HY; Chang JH; Chiu NC; Hsieh WS
    Dev Med Child Neurol; 2008 Jan; 50(1):51-7. PubMed ID: 18173631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endostatin concentration in cord plasma predicts the development of bronchopulmonary dysplasia in very low birth weight infants.
    Janér J; Andersson S; Kajantie E; Lassus P
    Pediatrics; 2009 Apr; 123(4):1142-6. PubMed ID: 19336373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium and phosphorus homeostasis in very-low-birth-weight infants appropriate for gestational age fed human milk.
    Boehm G; Kirchner B
    Biomed Biochim Acta; 1988; 47(6):529-36. PubMed ID: 3240302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease.
    Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD
    Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of nutrition in the prevention and management of bronchopulmonary dysplasia.
    Biniwale MA; Ehrenkranz RA
    Semin Perinatol; 2006 Aug; 30(4):200-8. PubMed ID: 16860160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary outcomes in bronchopulmonary dysplasia.
    Bhandari A; Panitch HB
    Semin Perinatol; 2006 Aug; 30(4):219-26. PubMed ID: 16860162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants.
    Schmidt B; Roberts R; Millar D; Kirpalani H
    Neonatology; 2008; 93(4):284-7. PubMed ID: 18525211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current issues in nutritional management of very low birth weight infants.
    Hawthorne KM; Griffin IJ; Abrams SA
    Minerva Pediatr; 2004 Aug; 56(4):359-72. PubMed ID: 15457134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-4 and 13 concentrations in infants at risk to develop Bronchopulmonary Dysplasia.
    Baier RJ; Loggins J; Kruger TE
    BMC Pediatr; 2003 Aug; 3():8. PubMed ID: 12925236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sudden infant death syndrome in infants with bronchopulmonary dysplasia.
    Werthammer J; Brown ER; Neff RK; Taeusch HW
    Pediatrics; 1982 Mar; 69(3):301-4. PubMed ID: 7199705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age.
    Vohr BR; Poindexter BB; Dusick AM; McKinley LT; Wright LL; Langer JC; Poole WK;
    Pediatrics; 2006 Jul; 118(1):e115-23. PubMed ID: 16818526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.